Related Experiment Videos
Current concepts on interstitial lung disease in children
1James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis 46202-5225, USA.
Insights
Pediatric interstitial lung disease (ILD) is a rare, complex group of lung disorders in children. Research is ongoing to understand its causes, improve diagnosis, and develop targeted therapies to reduce serious illness and death.
Area of Science:
- Pediatric Pulmonology
- Rare Diseases
- Respiratory Medicine
Background:
- Pediatric interstitial lung disease (ILD) encompasses rare conditions affecting lung development and function in children.
- Unlike adults, children require ongoing lung growth, complicating ILD management and prognosis.
- Current knowledge regarding pathogenesis, prognosis, and treatment of pediatric ILD remains limited.
Purpose of the Study:
- To investigate the cellular mediators and genetic factors contributing to interstitial lung damage in children.
- To further define the various types of pediatric ILD and diagnostic modalities.
- To advance the development of targeted therapies for pediatric ILD.
Main Methods:
- Focus on defining cellular mediators of interstitial damage.
- Investigating the role of viral infections and genetic predispositions.
- Evaluating diagnostic tools including bronchoalveolar lavage, radiography, and biopsy.
Main Results:
- Ongoing research aims to elucidate the underlying mechanisms of pediatric ILD.
- Studies are refining the classification and diagnostic approaches for these rare conditions.
- Efforts are directed towards identifying specific therapeutic targets.
Conclusions:
- Understanding the unique challenges of pediatric ILD, including lung development, is crucial.
- Multidisciplinary research is essential for improving diagnosis and treatment outcomes.
- The ultimate goal is to reduce the significant morbidity and mortality associated with pediatric ILD.
Abstract:
Pediatric interstitial lung disease comprises a diverse group of rare conditions characterized by an infiltrative process, abnormal gas exchange, and restrictive lung disease. Although the disorder is similar to its adult counterpart, its course is complicated by the continued need for lung growth and differentiation in infants and children. Knowledge about the pathogenesis, prognosis, and treatment of pediatric interstitial lung disease is limited. Investigators are focusing on defining the cellular mediators of the interstitial damage and describing the role of viral infections in and possible genetic predisposition to interstitial lung disease. Clinicians continue to define the various types of interstitial lung disease and to evaluate the roles of bronchoalveolar lavage, radiography, and biopsy in diagnosis. Together, investigators are working toward the development of specific, targeted therapy that will reduce the significant morbidity and mortality seen in pediatric interstitial lung disease.